Document Detail

Update on use of Enhanced Imaging to Optimize Lymphadenectomy in Patients Undergoing Minimally Invasive Surgery for Urothelial Cancer of the Bladder.
MedLine Citation:
PMID:  23341374     Owner:  NLM     Status:  Publisher    
The most commonly used imaging modalities for diagnostic investigation of bladder carcinoma are contrast-enhanced computed tomography, magnetic resonance imaging, and positron emission tomography. More recently, radioisotope and fluorescence staining are being used before, or even during, open or laparoscopic surgery. We report recent results obtained with these imaging modalities and their limitations.
Lukas Lusuardi; Günter Janetschek
Related Documents :
18477224 - Evaluation of the newly established acne severity classification among japanese and kor...
22082744 - Histiocyte-rich xanthomatous pseudotumor mimicking relapse on positron emission tomogra...
25243754 - Seizure or shiver?: artifact in the electroconvulsive therapy electroencephalogram.
23285594 - Segmentation of biological target volumes on multi-tracer pet images based on informati...
12439564 - Fast and ultrafast non-echo-planar mr imaging techniques.
18477224 - Evaluation of the newly established acne severity classification among japanese and kor...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-23
Journal Detail:
Title:  Current urology reports     Volume:  -     ISSN:  1534-6285     ISO Abbreviation:  Curr Urol Rep     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100900943     Medline TA:  Curr Urol Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Urology and Andrology, Paracelsus Medical University Salzburg, Müllner Hauptstrasse 48, 5020, Salzburg, Austria,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Trimodality Therapy for Bladder Conservation in Treatment of Invasive Bladder Cancer.
Next Document:  Value of Fluorescence Cystoscopy in High Risk Non-muscle Invasive Bladder Cancer.